The global Myeloproliferative Disorder Treatment Market is witnessing substantial growth as advances in precision medicine, targeted therapies, and molecular diagnostics transform the treatment landscape for rare hematologic disorders. Myeloproliferative disorders (MPDs), also known as myeloproliferative neoplasms (MPNs), are a group of chronic blood cancers characterized by the excessive...